SREBF1 and fatty liver disease: The study found that baicalein inhibited SREBP1c/ChREBP, activated AMPK and PPARα signaling pathways, and modulate the processes of fatty acid synthesis, elongation, and oxidation, thereby exerting a preventive effect against liver steatosis caused by fructose consumption in rats (Li et al., 2022b).